Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × tocilizumab × Clear all

Sponsor

Conditions

Arthritis, Rheumatoid 4 Lymphoma, B-Cell 3 Hematologic Neoplasms 3 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Solid Tumors 1 Sarcoma, Kaposi 1 Respiratory Tract Infections 1 Respiratory Distress Syndrome 1 Pneumonia 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Nasopharyngeal Neoplasms 1 Multi-centric Castleman's Disease 1 Mesothelioma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphohistiocytosis, Hemophagocytic 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Castleman Disease 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 COVID-19 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 37 Paclitaxel 36 Carboplatin 31 Cyclophosphamide 22 Albumin-Bound Paclitaxel 20 atezolizumab 16 130-nm albumin-bound paclitaxel 16 Taxes 15 Doxorubicin 15 Cisplatin 13 Capecitabine 13 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 Everolimus 6 talazoparib 5 durvalumab 5 Biopsy 5 Bevacizumab 5 veliparib 4 spartalizumab 4 sacituzumab govitecan 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 trilaciclib 3 entinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡